| 产品描述: | Dyngo-4a是一种有效的dynamin抑制剂,作用于DynI (brain),DynI (rec),和DynII (rec),IC50分别为0.38 μM,1.1 μM,和 2.3 μM |
| 靶点: |
DynI (brain):0.38 μM;DynI (rec):1.1 μM;DynII (rec):2.3 μM;Dynamin |
| 体内研究: |
Hydroxy Dynasore (腹膜内注射;30 mg/kg;BoNT/A 注射前 1.5-2 小时) 在 CD-1 小鼠的膈神经-膈肌抽搐模型中再次提供 BoNT/A 诱导的麻痹保护。 |
| 细胞实验: |
Cell lines: αT3–1 or LβT2 cells Concentrations: 30 μM Incubation Time: 30 minutes Method: αT3-1 or LβT2 cells (2 × 106) were grown overnight in a 6-well culture dish and then serum starved for 2–4 hours. Cells were pretreated with either vehicle (0), dynasore (80μM), or dyngo (30μM) for 30 minutes. For dose-response studies, indicated doses of dynasore were used for a 30-minute pretreatment. After pretreatment, cells were treated with 0 or GnRHa (10 nM) for 10 minutes. Cells were then washed twice in PBS, lysed in radio-immunoprecipitation assay (RIPA) buffer and subjected to SDS-PAGE (acrylamide:bis-acrylamide ratio of 29:1) and electroblotted to polyvinylidene difluoride membranes. |
| 动物实验: |
Animal Models: Female CD-1 mice Dosages: 30 mg/kg Administration: i.p. |
| 参考文献: |
1. McCluskey A, et al. Traffic. 2013, 14(12), 1272-1289. 2. Harper CB, et al. J Biol Chem. 2011, 286(41), 35966-35976. 3. Gagliardi M, et al. J Cell Sci. 2014, 127(22), 4918-4926. 4. Harper CB, et al. J Biol Chem. 2011, 286(41):35966-76. 5. Edwards BS, et al. Endocrinology. 2016, 157(2):831-43. |
| 溶解性: |
Soluble in DMSO、Ethanol |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.956 ml |
14.779 ml |
29.559 ml |
| 5 mM |
0.591 ml |
2.956 ml |
5.912 ml |
| 10 mM |
0.296 ml |
1.478 ml |
2.956 ml |
| 50 mM |
0.059 ml |
0.296 ml |
0.591 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |